|
It was reported that the bd alaris smartsite low sorbing secondary set had separated.The following information was provided by the initial reporter: the bd alaris pump infusion set's tubing may separate, leak, or fail to prime.When this occurs: treatment will be delayed.There is potential for patient blood loss.The compromised administration set presents a route for infectious agents.Medication may spill, potentially exposing staff and patients to toxic medication (e.G., chemotherapy agents).Also, the spill may present a fall risk.Medication may be wasted.
|